• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Exclusive – EU regulator to decide on Pfizer booster at the start of October – source

September 23, 2021 by David Barret Leave a Comment

September 23, 2021

By Emilio Parodi and Francesco Guarascio

BRUSSELS (Reuters) – The European Medicines Agency (EMA) expects to decide in early October on the possible use of a booster dose of the Pfizer-BioNTech COVID-19 vaccine, a source with direct knowledge of the matter told Reuters.

It will be the EU drugs regulator’s first decision on boosters, the source said, after the U.S. Food and Drug Administration on Wednesday authorized a third dose of Pfizer for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

“EMA’s decision on the third dose of Pfizer is expected for the beginning of October,” the source said, declining to be named because of the sensitivity of the matter.

Pfizer declined to comment, while BioNTech was not immediately available for comment.

The EU regulator said on Sept. 6 it had begun its evaluation of data submitted by Pfizer and BioNTech for a booster dose to be given six months after the second dose in people 16 years of age and older.

Moderna is also expected to submit data to the EMA this month on its booster dose, an EU document said.

In an opinion issued in early September and republished by the EMA, the European Centre for Disease Prevention and Control (ECDC) said there was no urgent need to administer booster doses to fully vaccinated individuals in the general population.

But it also noted that additional doses should already be considered for people with severely weakened immune systems as part of their primary vaccination.

Many EU states have already decided to administer a booster dose despite facing higher legal risks without a formal decision to do so by the EMA.

The EU has signed three deals with Pfizer and BioNTech for a total of 2.4 billion doses.

The latest contract covers the supply of at least 900 million shots, a large part of which is likely to be needed only if boosters are considered necessary, or if new virus variants emerge against which existing vaccination is not effective.

Over 70% of the EU’s adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.

The ECDC has said crucial data on the need and safety of boosters are still missing, in part because it is not yet fully clear how long vaccines protect against the virus.

(Reporting by Emilio Parodi and Francesco Guarascio @fraguarascio; Additional reporting by Ludwig Burger; Editing by Josephine Mason and Jan Harvey)

Source Link Exclusive – EU regulator to decide on Pfizer booster at the start of October – source

David Barret
David Barret

Related posts:

  1. IFRC urges urgent global humanitarian support for Afghanistan
  2. Global reinsurance rates to keep rising next year – Moody’s
  3. Pro-Putin party heads for Russian election win after Navalny clampdown
  4. Italy reports 26 coronavirus deaths on Sunday, 3,838 new cases

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The Ice Age Squirrel That Enabled A Plant’s Resurrection 31,800 Years Later
  • The First Video Game Came Long Before Pong And Was Invented By A Manhattan Project Physicist
  • Monster Hoaxes In The Age Of AI: Seeing Isn’t Believing Anymore
  • Everyone Thought This Ancient City Was Destroyed By Plague. A New Analysis Says It Never Happened
  • The “Mind’s Eye” Doesn’t Focus Like Our Vision, Even For People Who Have One
  • Strep Throat Or Sore Throat: What’s The Difference?
  • Reptiles “Pee” Crystals, But What Are They Made Of? Scientists Wanted To Find Out
  • A Vaccine For Stomach Ulcers Might Be On The Cards, And It Could Fight Off Cancer Too
  • Only One Place On Earth Now Remains Mosquito-Free As Iceland Records First-Ever Sighting
  • This Is One Of The Only Groups Of People Outside Africa Who Had Virtually No Denisovan DNA
  • Puzzling “Transient” Lights In The 1950s Skies Focused Around Nuclear Testing Facilities, Intriguing Study Finds
  • The Maya Calendar Had A Way To Predict Eclipses That Was Accurate For Centuries
  • “Elon Owes You $100”: Musk’s SpaceX Settles Lawsuit With Cards Against Humanity
  • Eyes To The Skies! The Special Orionids Meteor Shower Peaks Tonight
  • Flying Spiders Are Real, But It’s Not As Frightening As It Sounds
  • It Can Rain Monkeys In Florida, And The Reason Why Dates Back To The 1930s
  • New “Ghost Particles” Data Hints At Why The Universe Is Not Made Of Antimatter
  • Human Hybrids May Have Been A Hidden Factor In The Extinction Of Neanderthals
  • Elon Musk’s Classified “Starshield” Satellites Are Emitting An Unusual Signal, Amateur Astronomer Finds
  • Getting To Uranus Could Take Half The Time With SpaceX’s Starship
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version